SCHEMBL7436614

SCHEMBL7436614

COc1cc2c(cc1OC)[C@H](CN)C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
HTR2A P28223 3/20 0.43
NQO2 P16083 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
TSHR P16473 1/20 0.41
MAOA P21397 1/20 0.41
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
SLC6A4 P31645 1/20 0.41
DRD3 P35462 1/20 0.41
KCNH2 Q12809 1/20 0.41
HCN4 Q9Y3Q4 1/20 0.41
RAD52 P43351 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL383341 1.00 CYP3A4 (0.43) CYP3A4MAPTHTR2ANQO2MTNR1A
SCHEMBL7911834 1.00 CYP3A4 (0.43) CYP3A4MAPTHTR2ANQO2MTNR1A
SCHEMBL31936524 1.00 CYP3A4 (0.43) CYP3A4MAPTHTR2ANQO2MTNR1A
SCHEMBL31549 1.00 CYP3A4 (0.43) CYP3A4MAPTHTR2ANQO2MTNR1A
Hydrochloric Acid SCHEMBL30081991 0.98 MAOA (0.42) CYP3A4MAPTHTR2ANQO2MTNR1A
Hydrochloric Acid SCHEMBL9427970 0.98 MAOA (0.42) CYP3A4MAPTHTR2ANQO2MTNR1A
Hydrochloric Acid SCHEMBL384338 0.98 MAOA (0.42) CYP3A4MAPTHTR2ANQO2MTNR1A
Hydrochloric Acid SCHEMBL7274416 0.98 MAOA (0.42) CYP3A4MAPTHTR2ANQO2MTNR1A
SCHEMBL20041776 0.92 HTR2A (0.38) CYP3A4MAPTHTR2ANQO2MTNR1A
SCHEMBL3163151 0.88 TAAR1 (0.41) HTR2ANQO2MTNR1AMTNR1BCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9045788-B2 Process for the enzymatic synthesis of (7S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl) N-methyl methanamine, and application in the synthesis of ivabradine and salts thereof LES LABORATOIRES SERVIER (FR) 2015-06-02 US disclosed
US-9045788-B2 Process for the enzymatic synthesis of (7S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl) N-methyl methanamine, and application in the synthesis of ivabradine and salts thereof LES LABORATOIRES SERVIER (FR) 2015-06-02 US disclosed
US-20140024088-A1 PROCESS FOR THE ENZYMATIC SYNTHESIS OF (7S)-1-(3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7-YL) N-METHYL METHANAMINE, AND APPLICATION IN THE SYNTHESIS OF IVABRADINE AND SALTS THEREOF LES LABORATOIRES SERVIER (FR) 2014-01-23 US disclosed
US-20140024088-A1 PROCESS FOR THE ENZYMATIC SYNTHESIS OF (7S)-1-(3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7-YL) N-METHYL METHANAMINE, AND APPLICATION IN THE SYNTHESIS OF IVABRADINE AND SALTS THEREOF LES LABORATOIRES SERVIER (FR) 2014-01-23 US disclosed
EP-0534859-A1 Benzocyclobutyl- or indanyl-alkyl-amino-alkyl substituted 3-benzazepin-2-ones useful in the treatment of cardiovascular diseases ADIR ET COMPAGNIE (FR) 1993-03-31 EP disclosed